<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190908044722N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-12-24</date_registration>
      <primary_sponsor>Faculty of Physical Education  and Sport Sciences, University of Tehran,Tehran, Iran</primary_sponsor>
      <public_title>The Effectiveness of Three Interventions on Balance, Gait and Cognition among Man Schizophrenia Patients with Depression Disorder</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Aerobic Exercise, Computerized Cognitive Rehabilitation, tDCS on Balance, Gait and Cognition among Man Schizophrenia Patients with Depression Disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-07-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/42041</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>schizophrenia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:Aerobic training group: Participants will been enrolled  in AT will  undergo a 12-week, 3 sessions per week, 1-h AT training program informed by the American College of Sports Medicine and federal guidelines which recommend 150 min of moderate-intensity AT per week. The AT sessions will been led by a trainer (Bachelor of Physical Eduation) and  will been opened with a10-min trainer-led warm-up (stretching, slow walking) period, will been followed by 45-min AT using the equipment, and will been ended with a 5-min cooldown period The AT equipment will include two stationary bike,a treadmill machine. The trainer will be present during the AT sessions for guidance and support. AT intensity will be set to 60% of Hrmax in Week 1, 65% of Hrmax in Week 2, 70% of Hrmax  in Week 3, and 75% of  Hrmax in Weeks 4–12. Intervention 2: Intervention group 2: computerized cognitive training group : Cognitive rehabilitation was carried out using a cognitive rehabilitation program called the Attentive Rehabilitation of Attention and Memory (ARAM). This program is a kind of software designed to enhance the cognitive abilities created by Nejati and in some reports, its effectiveness was shown on executive functions.The program included a group of organized hierarchical tasks that enhanced the various dimensions of attention (selective, sustained, shifting, and divided) and working memory. These practices are hierarchical. This means that the therapist records the information obtained from the evaluation of the sessions, including the percentage of the correct responses of the client and task completion speed. If the client masters a task, the therapist increases the diffculty level of the task. Participations will been enrolled in CCT will  attend in the  computerized cognitive training session for 45–60 minutes three times weekly for 12 weeks (36 total sessions). Intervention 3: Intervention group 3: a-tDCS group: The anode stimulstion group  will receive  on the motor and pre-motor region for 24 sessions, two times weekly over 12 weeks. That way, in the morning will been given stimulation of the right hemisphere and in the  afternoon will been given stimulation of the left area .The anode electrode will been placed on the motor and pre-motor  and the cathode electrode will been placed in the center of the forehead. Also, the a-tDCS group, will receive stimulation on F3 for 24 sessions, two times weekly over 12 weeks. The anode  will been  placed over  the left DlPFC  and the cathode  will been placed on the contralateral deltoid muscle.The maximum current intensity will be 2 mA. Intervention 4: Intervention group4: multidimensional training group  : The multidimensional training consist of aerobic training, cognitive training, and direct electrical stimulation of the brain. Participations will been enrolled in MT will  attend in the  computerized cognitive training session for 10 minutes 3 times weekly for 12 weeks (36 total sessions). Also, They will undergo a 8 weeks, 2 sessions per week, 1-h AT training program. Minimal AT intensity will be set to 60% of Hrmax in Week 1, 65% of Hrmax in Week 2, 70%  of Hrmax in Week 3, and 75% of Hrmax in Weeks 4–12. During the exercise sessions, heart rate will been monitored using a Beurer PM 15 Heart Monitor. Participants will receive stimulation at the motor and pre-motor point in the right and left hemispheres from  9th  to 12 th week. In the morning area  will been given stimulation of the right hemisphere and in the  afternoon stimulation of the left area  . The anode electrode will been placed on the (M1) motor and pre-motor region and the cathode electrode  will been placed in the center of the forehead. Also Participants will receive stimulation on F3 for 12 sessions during 4 weeks (3 times per week). Electrode anode  will been placed on the left posterior frontal cortex And the cathode electrode will been placed on the opposite side of the deltoid muscle. Intervention 5: control group: Routine care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The analysis of information obtained from the results of the interventions on balance and gait speed can be published

When:
From the time the article was published until a year later

To whom:
All researchers

Conditions:
Provided Someone wants to do a similar research project

Where to obtain:
r.khanmohamadi65@yahoo.com

How to obtain:
Send request by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Razieh Khanmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between Fifteenth and Sixteenth St, Amirabad St, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3813978344</zip>
        <telephone>+98 918 624 2003</telephone>
        <email>r.khanmohamadi65@yahoo.com</email>
        <affiliation>University of Tehran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Razieh Khanmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between Fifteenth and Sixteenth St, Amirabad St, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3813978344</zip>
        <telephone>+98 86 3221 4311</telephone>
        <email>r.khanmohamadi65@yahoo.com</email>
        <affiliation>University of Tehran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Fulfillment of DSM-IV criteria for schizophrenia
The age 18–65 years
The ability to understand and  speak
Get a score of 11 or above on the Mini-Mental State Examination
Get a score of 11 or above on the Beck Depression Inventory
Having physical health, meaning that they have no evidence of cardiovascular, neuromuscular, endocrine or another somatic disorders</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Alcohol or substance dependence in the past 3 months
Substance dependence with current substance abuse (excluding nicotine)
History of head injury
Previous seizures
Having brain implants, cardiac pacemakers
Use of antiepileptic drugs or benzodiazepines &gt; 1 mg Lorazepam  equivalent
Having severe diabetes and asthma
Diagnosis of acute schizophrenia requiring hospitalization, presence of severe schizophrenic symptoms (e.g. persistent withdrawal)  that would limit participation in class
A history of organic mental disorders (e.g. mental retardation or dementia), presence of physical disabilities
Untreated hyper- or hypothyroidism
Extreme obesity (BMI ≥ 40);
Concurrent participation in another study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F98</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:Aerobic training group: Participants will been enrolled  in AT will  undergo a 12-week, 3 sessions per week, 1-h AT training program informed by the American College of Sports Medicine and federal guidelines which recommend 150 min of moderate-intensity AT per week. The AT sessions will been led by a trainer (Bachelor of Physical Eduation) and  will been opened with a10-min trainer-led warm-up (stretching, slow walking) period, will been followed by 45-min AT using the equipment, and will been ended with a 5-min cooldown period The AT equipment will include two stationary bike,a treadmill machine. The trainer will be present during the AT sessions for guidance and support. AT intensity will be set to 60% of Hrmax in Week 1, 65% of Hrmax in Week 2, 70% of Hrmax  in Week 3, and 75% of  Hrmax in Weeks 4–12</i_keyword>
      <i_keyword>Intervention group 2: computerized cognitive training group : Cognitive rehabilitation was carried out using a cognitive rehabilitation program called the Attentive Rehabilitation of Attention and Memory (ARAM). This program is a kind of software designed to enhance the cognitive abilities created by Nejati and in some reports, its effectiveness was shown on executive functions.The program included a group of organized hierarchical tasks that enhanced the various dimensions of attention (selective, sustained, shifting, and divided) and working memory. These practices are hierarchical. This means that the therapist records the information obtained from the evaluation of the sessions, including the percentage of the correct responses of the client and task completion speed. If the client masters a task, the therapist increases the diffculty level of the task. Participations will been enrolled in CCT will  attend in the  computerized cognitive training session for 45–60 minutes three times weekly for 12 weeks (36 total sessions).</i_keyword>
      <i_keyword>Intervention group 3: a-tDCS group: The anode stimulstion group  will receive  on the motor and pre-motor region for 24 sessions, two times weekly over 12 weeks. That way, in the morning will been given stimulation of the right hemisphere and in the  afternoon will been given stimulation of the left area .The anode electrode will been placed on the motor and pre-motor  and the cathode electrode will been placed in the center of the forehead. Also, the a-tDCS group, will receive stimulation on F3 for 24 sessions, two times weekly over 12 weeks. The anode  will been  placed over  the left DlPFC  and the cathode  will been placed on the contralateral deltoid muscle.The maximum current intensity will be 2 mA.</i_keyword>
      <i_keyword>Intervention group4: multidimensional training group  : The multidimensional training consist of aerobic training, cognitive training, and direct electrical stimulation of the brain. Participations will been enrolled in MT will  attend in the  computerized cognitive training session for 10 minutes 3 times weekly for 12 weeks (36 total sessions). Also, They will undergo a 8 weeks, 2 sessions per week, 1-h AT training program. Minimal AT intensity will be set to 60% of Hrmax in Week 1, 65% of Hrmax in Week 2, 70%  of Hrmax in Week 3, and 75% of Hrmax in Weeks 4–12. During the exercise sessions, heart rate will been monitored using a Beurer PM 15 Heart Monitor. Participants will receive stimulation at the motor and pre-motor point in the right and left hemispheres from  9th  to 12 th week. In the morning area  will been given stimulation of the right hemisphere and in the  afternoon stimulation of the left area  . The anode electrode will been placed on the (M1) motor and pre-motor region and the cathode electrode  will been placed in the center of the forehead. Also Participants will receive stimulation on F3 for 12 sessions during 4 weeks (3 times per week). Electrode anode  will been placed on the left posterior frontal cortex And the cathode electrode will been placed on the opposite side of the deltoid muscle</i_keyword>
      <i_keyword>control group: Routine care</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Static balance. Timepoint: Before the intervention and after the intervention. Method of measurement: The test of standing on dominant foot with open and closed eyes.</prim_outcome>
      <prim_outcome>Dynamic Balance. Timepoint: Before the intervention and after the intervention. Method of measurement: The Test of Timed up and Go.</prim_outcome>
      <prim_outcome>10-meter gait speed. Timepoint: Before the intervention and after the intervention. Method of measurement: The Test of 10-meter gait speed.</prim_outcome>
      <prim_outcome>Of  10-meter gait speed under visuospatial dual-task condition. Timepoint: Before the intervention and after the intervention. Method of measurement: The Test of  10-meter gait speed under visuospatial dual-task condition.</prim_outcome>
      <prim_outcome>Of  10-meter gait speed under motor  dual-task condition. Timepoint: Before the intervention and after the intervention. Method of measurement: The Test of  10-meter gait speed under motor  dual-task condition.</prim_outcome>
      <prim_outcome>Sustain attention. Timepoint: One month before intervention and two weeks after intervention. Method of measurement: Continuous Performance Test.</prim_outcome>
      <prim_outcome>Response Inhibition. Timepoint: One month before intervention and two weeks after intervention. Method of measurement: Stroop Test.</prim_outcome>
      <prim_outcome>Working Memory. Timepoint: One month before intervention and two weeks after intervention. Method of measurement: N-back Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faculty of Physical Education  and Sport Sciences, University of Tehran,Tehran, Iran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-01</approval_date>
        <contact_name>Ethics committee of Sport Sciences Research Institute</contact_name>
        <contact_address>No. 3, Fifth Alley, Miramad Street, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
